Kamunting Street Capital Management’s Celgene Corp CELG Stock Holding History

Kamunting Street Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-26,000	Closed	-$1.67M	–	53
2018 Q4	$1.67M	Buy	26,000 +15,000	+136%	+$1.11M	1.53%	13
2018 Q3	$984K	Hold	11,000	–	–	0.9%	15
2018 Q2	$874K	Hold	11,000	–	–	1.21%	16
2018 Q1	$981K	Hold	11,000	–	–	0.77%	21
2017 Q4	$1.15M	Buy	+11,000	New	+$1.24M	0.82%	22

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kamunting Street Capital Management's CELG Position: Q1 2019 in Review

Kamunting Street Capital Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 26,000 shares — an estimated $1.67M sold.

Kamunting Street Capital Management first reported a position in CELG in Q4 2017 and held it in 5 quarters. The position peaked at $1.67M in Q4 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

Kamunting Street Capital Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
Kamunting Street Capital Management sold 26,000 Celgene Corp shares in Q1 2019, an estimated $1.67M.
Kamunting Street Capital Management first reported a position in Celgene Corp in Q4 2017 and held it in 5 quarters.
Kamunting Street Capital Management's Celgene Corp position peaked at $1.67M in Q4 2018.
1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Kamunting Street Capital Management's 13F filing for Q1 2019, filed 15 May 2019.